vs
Side-by-side financial comparison of DuPont (DD) and LyondellBasell (LYB), based on the latest 10-Q / 10-K filings. Click either name above to swap in a different company.
DuPont runs the higher net margin — 4.9% vs -2.0%, a 6.9% gap on every dollar of revenue. On growth, LyondellBasell posted the faster year-over-year revenue change (-25.3% vs -182.3%). LyondellBasell produced more free cash flow last quarter ($1.1B vs $-850.0M). Over the past eight quarters, LyondellBasell's revenue compounded faster (-15.5% CAGR vs NaN%).
DuPont de Nemours, Inc., commonly shortened to DuPont, is an American multinational chemical company first formed in 1802 by French-American chemist and industrialist Éleuthère Irénée du Pont de Nemours. The company played a major role in the development of the U.S. state of Delaware and first arose as a major supplier of gunpowder.
LyondellBasell Industries N.V. is an American multinational chemical company, incorporated in the Netherlands with U.S. operations headquartered in Houston, Texas and offices in London, UK. The company is the largest licensor of polyethylene and polypropylene technologies. It also produces ethylene, propylene, polyolefins, and oxyfuels.
DD vs LYB — Head-to-Head
Income Statement — Q4 2025 vs Q4 2025
| Metric | | |
|---|---|---|
| Revenue | $-2.5B | $7.1B |
| Net Profit | $-126.0M | $-140.0M |
| Gross Margin | — | 4.7% |
| Operating Margin | — | -1.2% |
| Net Margin | 4.9% | -2.0% |
| Revenue YoY | -182.3% | -25.3% |
| Net Profit YoY | -6.8% | 76.8% |
| EPS (diluted) | $-0.30 | $-0.45 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align — see 8-quarter trend below.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history — bar widths are scaled to the larger of the two companies so you can eyeball the size gap and growth trajectory without doing math. Quarters aligned by calendar period (report date) so offset fiscal years line up.
| Q4 25 | $-2.5B | $7.1B | ||
| Q3 25 | $3.1B | $7.7B | ||
| Q2 25 | $3.3B | $7.7B | ||
| Q1 25 | $3.1B | $7.7B | ||
| Q4 24 | $3.1B | $9.5B | ||
| Q3 24 | $3.2B | $10.3B | ||
| Q2 24 | $3.2B | $10.6B | ||
| Q1 24 | $2.9B | $9.9B |
| Q4 25 | $-126.0M | $-140.0M | ||
| Q3 25 | $-123.0M | $-890.0M | ||
| Q2 25 | $59.0M | $115.0M | ||
| Q1 25 | $-589.0M | $177.0M | ||
| Q4 24 | $-118.0M | $-603.0M | ||
| Q3 24 | $454.0M | $573.0M | ||
| Q2 24 | $178.0M | $924.0M | ||
| Q1 24 | $189.0M | $473.0M |
| Q4 25 | — | 4.7% | ||
| Q3 25 | 38.9% | 11.7% | ||
| Q2 25 | 37.3% | 10.3% | ||
| Q1 25 | 37.4% | 7.2% | ||
| Q4 24 | 36.4% | 7.9% | ||
| Q3 24 | 37.4% | 12.0% | ||
| Q2 24 | 37.1% | 13.4% | ||
| Q1 24 | 34.6% | 11.7% |
| Q4 25 | — | -1.2% | ||
| Q3 25 | 10.6% | -9.5% | ||
| Q2 25 | 9.4% | 3.7% | ||
| Q1 25 | -14.0% | 1.5% | ||
| Q4 24 | 1.4% | -6.9% | ||
| Q3 24 | 18.4% | 7.8% | ||
| Q2 24 | 9.3% | 9.2% | ||
| Q1 24 | 9.1% | 7.1% |
| Q4 25 | 4.9% | -2.0% | ||
| Q3 25 | -4.0% | -11.5% | ||
| Q2 25 | 1.8% | 1.5% | ||
| Q1 25 | -19.2% | 2.3% | ||
| Q4 24 | -3.8% | -6.3% | ||
| Q3 24 | 14.2% | 5.6% | ||
| Q2 24 | 5.6% | 8.8% | ||
| Q1 24 | 6.4% | 4.8% |
| Q4 25 | $-0.30 | $-0.45 | ||
| Q3 25 | $-0.29 | $-2.77 | ||
| Q2 25 | $0.14 | $0.34 | ||
| Q1 25 | $-1.41 | $0.54 | ||
| Q4 24 | $-0.28 | $-1.86 | ||
| Q3 24 | $1.08 | $1.75 | ||
| Q2 24 | $0.42 | $2.82 | ||
| Q1 24 | $0.45 | $1.44 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest filing — the kind of financial-strength check premium terminals charge for.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $715.0M | $5.5B |
| Total DebtLower is stronger | $3.1B | $12.1B |
| Stockholders' EquityBook value | $13.9B | $10.1B |
| Total Assets | $21.6B | $34.0B |
| Debt / EquityLower = less leverage | 0.23× | 1.20× |
8-quarter trend — quarters aligned by calendar period so offset fiscal years match up.
| Q4 25 | $715.0M | $5.5B | ||
| Q3 25 | $2.0B | $2.5B | ||
| Q2 25 | $1.8B | $2.5B | ||
| Q1 25 | $1.8B | $3.0B | ||
| Q4 24 | $1.9B | $6.0B | ||
| Q3 24 | $1.6B | $4.3B | ||
| Q2 24 | $1.5B | $4.7B | ||
| Q1 24 | $1.9B | $3.8B |
| Q4 25 | $3.1B | $12.1B | ||
| Q3 25 | $7.0B | $10.6B | ||
| Q2 25 | $5.3B | $11.2B | ||
| Q1 25 | $5.3B | $10.6B | ||
| Q4 24 | $5.3B | $10.5B | ||
| Q3 24 | $7.2B | $11.1B | ||
| Q2 24 | $7.2B | $11.0B | ||
| Q1 24 | $7.8B | $11.0B |
| Q4 25 | $13.9B | $10.1B | ||
| Q3 25 | $22.9B | $10.6B | ||
| Q2 25 | $23.1B | $11.9B | ||
| Q1 25 | $22.8B | $12.2B | ||
| Q4 24 | $23.4B | $12.5B | ||
| Q3 24 | $24.2B | $13.7B | ||
| Q2 24 | $23.3B | $13.4B | ||
| Q1 24 | $23.6B | $13.0B |
| Q4 25 | $21.6B | $34.0B | ||
| Q3 25 | $38.0B | $33.8B | ||
| Q2 25 | $36.6B | $35.4B | ||
| Q1 25 | $36.0B | $35.2B | ||
| Q4 24 | $36.6B | $35.7B | ||
| Q3 24 | $37.5B | $37.3B | ||
| Q2 24 | $36.6B | $37.1B | ||
| Q1 24 | $37.7B | $36.6B |
| Q4 25 | 0.23× | 1.20× | ||
| Q3 25 | 0.31× | 1.00× | ||
| Q2 25 | 0.23× | 0.94× | ||
| Q1 25 | 0.23× | 0.87× | ||
| Q4 24 | 0.23× | 0.85× | ||
| Q3 24 | 0.30× | 0.81× | ||
| Q2 24 | 0.31× | 0.82× | ||
| Q1 24 | 0.33× | 0.85× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Net income can be massaged; cash flow is harder to fake.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-700.0M | $1.5B |
| Free Cash FlowOCF − Capex | $-850.0M | $1.1B |
| FCF MarginFCF / Revenue | 33.4% | 14.9% |
| Capex IntensityCapex / Revenue; lower = less reinvestment burden | -5.9% | 6.3% |
| Cash ConversionOCF / Net Profit; >1× = earnings back up with cash | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-73.0M | $384.0M |
8-quarter trend — quarters aligned by calendar period so offset fiscal years match up.
| Q4 25 | $-700.0M | $1.5B | ||
| Q3 25 | $497.0M | $983.0M | ||
| Q2 25 | $381.0M | $351.0M | ||
| Q1 25 | $382.0M | $-579.0M | ||
| Q4 24 | $564.0M | $1.9B | ||
| Q3 24 | $737.0M | $670.0M | ||
| Q2 24 | $527.0M | $1.3B | ||
| Q1 24 | $493.0M | $-114.0M |
| Q4 25 | $-850.0M | $1.1B | ||
| Q3 25 | $379.0M | $577.0M | ||
| Q2 25 | $265.0M | $-188.0M | ||
| Q1 25 | $133.0M | $-1.1B | ||
| Q4 24 | $403.0M | $1.4B | ||
| Q3 24 | $628.0M | $302.0M | ||
| Q2 24 | $425.0M | $864.0M | ||
| Q1 24 | $286.0M | $-597.0M |
| Q4 25 | 33.4% | 14.9% | ||
| Q3 25 | 12.3% | 7.5% | ||
| Q2 25 | 8.1% | -2.5% | ||
| Q1 25 | 4.3% | -13.8% | ||
| Q4 24 | 13.0% | 14.9% | ||
| Q3 24 | 19.7% | 2.9% | ||
| Q2 24 | 13.4% | 8.2% | ||
| Q1 24 | 9.8% | -6.0% |
| Q4 25 | -5.9% | 6.3% | ||
| Q3 25 | 3.8% | 5.3% | ||
| Q2 25 | 3.6% | 7.0% | ||
| Q1 25 | 8.1% | 6.3% | ||
| Q4 24 | 5.2% | 5.3% | ||
| Q3 24 | 3.4% | 3.6% | ||
| Q2 24 | 3.2% | 4.6% | ||
| Q1 24 | 7.1% | 4.9% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 6.46× | 3.05× | ||
| Q1 25 | — | -3.27× | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.62× | 1.17× | ||
| Q2 24 | 2.96× | 1.46× | ||
| Q1 24 | 2.61× | -0.24× |
Financial Flow Comparison
Sankey diagram of revenue → gross profit → operating profit → net profit for each company. Charts shown full-width and stacked so both segment hierarchies are readable side-by-side on desktop and mobile.
Revenue Breakdown by Segment
DD
Segment breakdown not available.
LYB
| Polypropylene | $1.3B | 18% |
| Oxyfuels And Related Products | $1.3B | 18% |
| Olefins And Co Products | $1.1B | 15% |
| Advanced Polymer Solutions | $774.0M | 11% |
| Po And Derivatives | $497.0M | 7% |
| Other | $492.0M | 7% |
| DE | $440.0M | 6% |
| MX | $353.0M | 5% |
| Intermediate Chemicals | $341.0M | 5% |
| Discontinued Operations Disposed Of By Means Other Than Sale | $265.0M | 4% |
| Other Products | $199.0M | 3% |
| Related Party | $126.0M | 2% |
